Nuclea Energy to Go Public via Combination with Mangoceuticals
August 2, 2026
Nuclea Energy entered into a definitive business combination agreement with publicly traded Mangoceuticals to pursue a Nasdaq listing. The deal will be implemented through a newly formed indirect subsidiary of Mangoceuticals amalgamating with Nuclea, with former Nuclea shareholders expected to own about 96% of Mangoceuticals before a planned private investment.
- Buyers
- Mangoceuticals
- Targets
- Nuclea Energy
- Industry
- Energy
- Location
- British Columbia, Canada
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.